Literature DB >> 1026559

Isolation and identification of paracetamol metabolites.

R S Andrews, C C Bond, J Burnett, A Saunders, K Watson.   

Abstract

A comparison has been made of the urinary metabolites of volunteers who had taken therapeutic doses of paracetamol with those of persons who had taken an overdose in an attempt to highlight the metabolic changes associated with massive doses. The main technique for examining urine samples was two-dimensional thin layer chromatography. Other chromatographic techniques were used for the isolation and purification of metabolites. The urinary metabolites after a therapeutic dose of paracetamol were identified as free paracetamol, paracetamol sulphate, 3-hydroxy-paracetamol-3-sulphate, 3-methoxy-paracetamol sulphate, paracetamol glucuronide, 3-methoxy-paracetamol glucuronide, paracetamol 3-cysteine conjugate and paracetamol 3-mercapturate. The same metabolites were also present in urine following overdosage but the proportions were quite different. There was particularly a big increase in the relative amounts of cysteine and mercapturic acid conjugates excreted. No new metabolites were found. The significance of these findings is briefly discussed in relation to the metabolism and toxicology of paracetamol.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1026559     DOI: 10.1177/14732300760040S408

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  8 in total

Review 1.  Paracetamol.

Authors:  T J Meredith; R Goulding
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

2.  The metabolism and toxicity of paracetamol in Sprague-Dawley and Wistar rats.

Authors:  S J Hart; I C Calder; J D Tange
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1982       Impact factor: 2.441

3.  Acetaminophen elimination half-life in humans is unaffected by short-term consumption of sulfur amino acid-free diet.

Authors:  Yanci O Mannery; Thomas R Ziegler; Youngja Park; Dean P Jones
Journal:  J Pharmacol Exp Ther       Date:  2010-03-05       Impact factor: 4.030

4.  Inhibition of the metabolism of paracetamol by isoniazid.

Authors:  M M Epstein; S D Nelson; J T Slattery; T F Kalhorn; R A Wall; J M Wright
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

5.  The purinergic P2Y14 receptor links hepatocyte death to hepatic stellate cell activation and fibrogenesis in the liver.

Authors:  Ingmar Mederacke; Aveline Filliol; Silvia Affo; Ajay Nair; Celine Hernandez; Qiuyan Sun; Florian Hamberger; Francesco Brundu; Yu Chen; Aashreya Ravichandra; Peter Huebener; Helena Anke; Hongxue Shi; Raquel A Martínez García de la Torre; James R Smith; Neil C Henderson; Florian W R Vondran; Carla V Rothlin; Heike Baehre; Ira Tabas; Pau Sancho-Bru; Robert F Schwabe
Journal:  Sci Transl Med       Date:  2022-04-06       Impact factor: 19.319

Review 6.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of paracetamol.

Authors:  J A Forrest; J A Clements; L F Prescott
Journal:  Clin Pharmacokinet       Date:  1982 Mar-Apr       Impact factor: 6.447

8.  The Alzheimer pandemic: is paracetamol to blame?

Authors:  Günther Robert Norman Jones
Journal:  Inflamm Allergy Drug Targets       Date:  2014-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.